Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
March 14, 2024Frontiers in OncologyOpen Access

Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMeng ZhangYZYuxiao ZuoSCSi–Yi Chen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e740ffb6db6435876ba1cahttps://doi.org/10.3389/fonc.2024.1323366
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates2006 · 179 citations
  2. 2Brentuximab Vedotin (SGN-35)2011 · 365 citations
  3. 3UC Trials Get Standing Ovation2023 · 4 citations
  4. 4Recent advances of antibody drug conjugates for clinical applications2020 · 179 citations